Product Description
This recombinant vaccine utilizes fowlpox virus as a vector to express the gB gene of infectious laryngotracheitis virus (ILTV), providing simultaneous protection against both infectious laryngotracheitis (ILT) and fowlpox.
ILT is a highly contagious respiratory disease in chickens, leading to severe economic losses due to mortality and decreased productivity. Fowlpox, on the other hand, is a viral disease characterized by cutaneous lesions and reduced performance, particularly in backyard and free-range systems.
By combining these two disease targets into a single recombinant vaccine, this product offers an efficient and cost-effective immunization strategy. The fowlpox vector ensures high safety, as it does not revert to virulence, while effectively delivering ILT antigen to stimulate protective immunity.
Immunity develops following vaccination and provides protection for up to 5 months, making it suitable for broilers, layers, and breeder flocks, particularly in regions where both ILT and fowlpox are prevalent.
Immunization Program
- Suitable for chickens aged 21 days or older
- Single-dose vaccination
- Can be integrated into standard poultry vaccination programs
Dosage & Administration
- Dilute with sterile normal saline according to label instructions
- Route:
- Wing web (intradermal puncture at bloodless area)
- Dosage:
- 1 dose per bird
Composition
- Recombinant fowlpox virus expressing ILTV gB gene: ≥ 10⁴.⁰ PFU per dose
Product Characteristics
- Appearance: Light yellow loose pellet
- Rapid dissolution into pink solution after reconstitution
- Suitable for field vaccination
Safety & Adverse Reactions
- Generally no significant adverse reactions
Normal post-vaccination response:
- Mild redness and swelling at injection site (3–4 days)
- Occasional scab formation
- Recovery within approximately 14 days
These responses indicate successful vaccine take
Precautions
- Vaccinate only healthy chickens
- Do not use in:
- Emaciated birds
- Birds already exposed to fowlpox virus
- Inspect vaccine before use:
- Do not use damaged or contaminated vials
- After reconstitution:
- Store in cool, dark conditions
- Use within 4 hours
- Dispose of:
- Vaccine vials
- Equipment
- Residual vaccine according to biosafety protocols
Packaging & Specification
- Specifications:
- 1000 doses/vial
- 2000 doses/vial
- Packaging: 10 vials/box
Storage & Shelf Life
- Storage: 2–8°C
- Protect from light
- Shelf Life: 24 months
